Hot Natural Products & Bioactive Compounds
BioCrick offers high-purity natural products and bioactive compounds for scientific research. Our natural product collection includes compounds derived from plants, microorganisms and other biological sources and is widely used in pharmacological, biochemical and drug discovery research.
Natural products remain an important source of bioactive molecules and drug leads. BioCrick provides researchers with high-quality natural product compounds together with catalog numbers, product information and biological activity data.
Hot Products from BioCrick
Showing 1489 - 1496 of 9359 hot products
| Catalog No. | Product Name |
|---|---|
| BCC5888 | MNI-caged-NMDA |
|
NMDA caged with the photosensitive 4-methoxy-7-nitroindolinyl group.
|
|
| BCC5889 | L803-mts |
|
Selective peptide inhibitor of glycogen synthase kinase-3 (GSK-3). Produces antidepressive behavior in mice when administered <em>in vivo</em>. Shows no inhibition of PKC, PKB or cdc2 protein kinase. Exhibits insulin mimetic activity. Activates glycogen synthase activity 2.5-fold in HEK293 cells. Myristoylated version of L803.
|
|
| BCC5890 | GIP (1-39) |
|
Endogenous truncated form of the incretin hormone GIP. More potent at stimulating glucose-dependent insulin secretion from rat pancreatic <span class='symbol'>β</span>-cells than GIP.
|
|
| BCC5891 | GLP-2 (human) |
|
Endogenous peptide identified as an intestinal epithelium-specific growth factor; stimulates cell proliferation and inhibits apoptosis. Diverse effects on gastrointestinal function including regulation of intestinal glucose transport, food intake, and gastric acid secretion.
|
|
| BCC5892 | GLP-2 (rat) |
|
Endogenous peptide identified as an intestinal epithelium-specific growth factor; stimulates cell proliferation and inhibits apoptosis. Diverse effects on gastrointestinal function including regulation of intestinal glucose transport, food intake, and gastric acid secretion.
|
|
| BCC5893 | WRW4 |
|
Selective antagonist of formyl peptide receptor 2 (FPR2) signaling. Inhibits WKYMVm binding to FPR2 (IC<sub>50</sub> = 0.23 <span class='symbol'>μ</span>M) and inhibits intracellular calcium release induced by WKYMVm, MMK 1, amyloid <span class='symbol'>β</span>42, and F peptide. Also inhibits FPR2-mediated signaling in human neutrophils; blocks chemotactic migration and superoxide generation by amyloid <span class='symbol'>β</span>42 peptide.
|
|
| BCC5894 | Motilin (human, porcine) |
|
Endogenous motilin receptor ligand (Ki = 2.3 nM) that regulates gastrointestinal motor function. Stimulates contraction of gut smooth muscle (EC50 = 1 nM) and increases pepsin release.
|
|
| BCC5895 | Lyn peptide inhibitor |
|
Cell-permeable inhibitor of Lyn-dependent effects of the IL-5 receptor. Blocks binding of Lyn tyrosine kinase to <span class='symbol'>β</span>c subunit of IL-3/GM-CSF/IL-5 receptors, blocking Lyn activation. Inhibits IL-5 receptor-mediated eosinophil differentiation and survival <em>in vitro</em>. Inhibits airway eosinophilic inflammation in mouse model of asthma.
|
|